Announcement
22 Aug 2023
In August 2023, U.S. BARDA provided funding to support the development of a next-generation COVID-19 monoclonal antibody therapy.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
22 Aug 2023
Revocation date:
No revocation date
Updated: 22 Aug 2023
State aid, unspecified
In force
On 22 August 2023, the Biomedical Advanced Research and Development Authority (BARDA) of the United States announced awarding Regeneron Pharmaceuticals Inc a contract to support the development of a n...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.